Cell Culture Media for Vaccine Market
- 2026 年市場規模
- USD 2,217.6 Mn
- 2033 年預估規模
- USD 3,727.4 Mn
- 年複合成長率 CAGR
- 7.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cell Culture Media for Vaccine Market, By Media Type (Bovine Derived (Fetal bovine serum (FBS), Newborn Calf Serum (NBCS), Adult Bovine Serum (ABS), Bovine Serum Albumin (BSA), and Bovine Calf Serum (BCS)), Porcine Derived, and Animal free/Serum Free Cell Culture), By Application (Human Vaccines and Animal Vaccines), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.
Market Dynamics
Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).
Key features of the study
• This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter’s analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
• It profiles key players in the global cell culture media for vaccine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market
Market Segmentation
• By Media Type
o Bovine Derived
Fetal bovine serum (FBS)
Newborn Calf Serum (NBCS)
Adult Bovine Serum (ABS)
Bovine Serum Albumin (BSA)
Bovine Calf Serum (BCS)
o Porcine Derived
o Animal free/Serum Free Cell Culture
• By Application
o Human Vaccines
o Animal Vaccines
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o HiMedia Laboratories
o Thermo Fisher Scientific Inc.
o Merck KGaA
o General Electric Company
o Sartorius AG
o Proliant, Inc.
o Bovogen Biologicals Pty. Ltd.
o Rocky Mountain Biologicals
o Valley Biomedical
o Moregate BioTech
o Atlanta Biologicals
o Creative-Biolabs
o Life Technologies (India) Pvt Ltd.
o Axil Scientific Pte Ltd.
o Indian Immunologicals Limited
o Serum Institute of India Pvt. Ltd.
o Sisco Research Laboratories Pvt. Ltd.
o Valneva SE
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Media Type
Market Snippet, By Application
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Porter’s analysis
o PEST analysis
o Regulatory Scenario
o Key Developments
o Raw material analysis
o Supply chain analysis
4. Global Cell Culture Media for Vaccine Market, By Media Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Bovine Derived
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Fetal bovine serum (FBS)
o Newborn Calf Serum (NBCS)
o Adult Bovine Serum (ABS)
o Bovine Serum Albumin (BSA)
o Bovine Calf Serum (BCS)
o Porcine Derived
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Animal free/Serum Free Cell Culture
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Cell Culture Media for Vaccine Market, By Application, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Human Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Animal Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Cell Culture Media for Vaccine Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
o North America
Market Size and Forecast, By Media Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Media Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Media Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Media Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Media Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Media Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
HiMedia Laboratories
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Thermo Fisher Scientific Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck KGaA
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
General Electric Company
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sartorius AG
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Proliant, Inc.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bovogen Biologicals Pty. Ltd.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Rocky Mountain Biologicals
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Valley Biomedical
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Moregate BioTech
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Atlanta Biologicals
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Creative-Biolabs
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Life Technologies (India) Pvt Ltd.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Axil Scientific Pte Ltd.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Indian Immunologicals Limited
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Serum Institute of India Pvt. Ltd.
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Valneva SE
o Company Overview
o Product Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們